June 01, 2026
One of the most clinically important facts about fatty liver disease — and one of the least clearly communicated to patients — is that you can have significant fat accumulation in your liver and feel completely, entirely normal. No pain. No fatigue that you can clearly attribute to your liver. No yellowing of the skin. Nothing that signals to you that something in your liver needs attention. This is not a reassuring fact. It is the reason fatty liver progresses silently in so many patients until it is significantly more advanced than it needed to be.
The liver has no pain receptors of its own. It cannot send you a pain signal to alert you to fat accumulation, rising enzyme levels, or early inflammatory changes. The nerve fibres that produce pain are in the liver capsule — the outer covering — and these are only activated when the liver is significantly enlarged and the capsule is stretched. By that point, the condition has usually progressed well beyond its most reversible phase. In the early stages (Grade 1 and even Grade 2), the liver continues to perform its functions — producing proteins, processing nutrients, filtering blood — without producing symptoms that would prompt medical attention. The only way to find early fatty liver is to look for it: through a liver ultrasound or liver enzyme blood test, typically during a routine health checkup or as part of an investigation for something else.
When patients with newly diagnosed fatty liver reflect on whether they felt any different, some do identify in retrospect: slightly more fatigue than they expected, a mild upper right abdominal fullness or heaviness after large meals, or a vague sense that their digestion was not quite right. But these symptoms are non-specific — they could be attributed to dozens of other things — and most patients had not considered them clinically significant enough to investigate. The clinical lesson: fatigue and upper right discomfort in the context of metabolic risk factors (obesity, PCOS, type 2 diabetes, significant alcohol use) warrant a liver ultrasound. They are not diagnostic of fatty liver — but they are reasons to look. Read: liver health and fatty liver complete guide.
The absence of symptoms is not evidence of absence of disease. Grade 1 fatty liver in a patient with insulin resistance, type 2 diabetes, and continued refined carbohydrate overconsumption can progress to Grade 2, then to Grade 3, then to fibrosis — all while the patient feels normal. The inflection point — where the liver's compensation mechanisms fail and symptoms emerge — typically corresponds to significant fibrosis or cirrhosis. At that point, the condition is significantly harder to reverse and management is more complex. Treating fatty liver early — when the patient feels normal and the condition is still highly reversible — is not an academic exercise. It is the clinical window that produces the best outcomes. Read our reversal guide: can lifestyle reverse fatty liver.
Fatty liver screening with liver ultrasound is appropriate for adults in Pune and Mumbai with any of the following: BMI above 23 with abdominal obesity; type 2 diabetes or confirmed prediabetes; fasting triglycerides consistently above 150 mg/dL; PCOS with metabolic features; regular alcohol consumption above seven units per week; or unexplained elevation in ALT on a routine blood panel. These are the populations in whom fatty liver is most prevalent and in whom early detection most changes the outcome. Read the enzyme guide: elevated ALT and AST in Indians.
Yes — and this is a critically important clinical fact. Up to 30–40% of patients with ultrasound-confirmed Grade 1 and Grade 2 fatty liver have normal ALT and AST levels. Liver enzymes become elevated when liver cell damage is occurring — but fat accumulation without significant inflammation can be present without enzyme elevation. Normal enzymes do not rule out fatty liver. An ultrasound is the diagnostic tool, not a blood test alone.
If you have one or more of the metabolic risk factors listed above — yes. The value of the ultrasound is precisely that it detects fatty liver before you would know about it any other way. Finding Grade 1 fatty liver and acting on it consistently is significantly more effective than finding Grade 3 fatty liver because symptoms finally prompted investigation. This is the clinical logic of screening — it produces better outcomes by finding problems when they are more fixable.
Do not dismiss it as "just something to watch." Do get a full metabolic workup: fasting insulin, HOMA-IR, liver function panel, full lipid profile. Do understand your fatty liver grade and what it means (see: fatty liver grades explained). Do build a specific, practical plan to address the metabolic drivers — with clinical guidance if needed. Do schedule a follow-up ultrasound at six to twelve months to assess response. The incidental finding is a gift — it is catching the problem in its most manageable phase.
Yes — ultrasound is not sensitive enough to detect early fibrosis (liver scarring) alongside steatosis. A liver with Grade 1 steatosis on ultrasound may also have early fibrosis that the ultrasound cannot reliably detect. Fibroscan (liver elastography) is the non-invasive tool that assesses fibrosis stage separately from fat content. Patients with Grade 2 or 3 fatty liver, particularly with elevated enzymes or significant metabolic risk factors, should have fibroscan assessment alongside ultrasound.
Yes — paediatric MASLD is an increasing clinical concern in urban India, driven by sedentary lifestyles, high sugar consumption, and the same insulin resistance drivers as in adults. Children with fatty liver almost universally feel asymptomatic, and the condition is typically discovered incidentally during ultrasound for other indications or as part of obesity-related health screening. If your child has been diagnosed with fatty liver, a paediatric hepatologist or metabolic specialist assessment is the appropriate referral.